XML 26 R18.htm IDEA: XBRL DOCUMENT v3.7.0.1

Note 1 - Nature of the Business and Basis of Preparation (Tables)

3 Months Ended

Mar. 31, 2017

Notes Tables

Schedule of Subsidiaries [Table Text Block]

Name of company		Place of incorporation		Date of incorporation		Percentage of ownership by the Company		Principal activities
BeyondSpring Pharmaceuticals Inc.		Delaware, United States of America (“U.S.”)		June 18, 2013		100%		Clinical trial activities
BeyondSpring Ltd.		The British Virgin Islands (“BVI”)		December 3, 2014		100%		Holding company
BeyondSpring (HK) Limited		Hong Kong		January 13, 2015		100%		Holding company
Wanchun Biotechnology Limited		BVI		April 1, 2015		100%		Holding company
Wanchun Biotechnology (Shenzhen) Ltd.		The People’s Republic of China (“PRC”)		April 23, 2015		100%		Holding company
Dalian Wanchunbulin Pharmaceuticals Ltd. (“Wanchunbulin”)		PRC		May 6, 2015		60%		Clinical trial activities
BeyondSpring Pharmaceuticals Australia PTY Ltd. (“BeyondSpring Australia”)		Australia		March 3, 2016		100%		Clinical trial activities

X

- Definition

A tabular disclosure of ownership percentage of subsidiaries of the company.

+ References

No definition available.

+ Details

Name:	bysi_ScheduleOfSubsidiariesTableTextBlock
Namespace Prefix:	bysi_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_TableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration